Heparinas de baixo peso molecular: que utilidade terapêutica?
Keywords:
.Abstract
.
Downloads
References
McLean J. "The thromboplastic action of cephalin".Am J Physiol 1916; 41:250-257
HirshJ, Fuster V. "Guide to anticoagulant therapy. Part 1: Hepa rin" Circulation, 1994;89:1449-1468
Kakkar VV, Corrigan TP, Fossard DP. Prevention of fatal postope rative pulmonary embolism by low doses of heparin. ln in ternational Multicenter Triai. Lancet II 1975, 45-51.
Kakkar VV, Murray WJG. Efficacy and Safety of low-molecular weight heparin (CY216) in preventing postoperative venous thromboembolism a cooperative study. Br J Surg 1985; 72: 786-791.
Levine M N, HirshJ, Gent M, et ai. "Prevention of deep vein throm bosis after elective hip surgery". Ann Intern Med, 1991; 114: 545-551.
Prandoni P, Lensing A W, Büller H R, et ai. "Comparison of subcutaneous low-molecular-weight heparin with intravenous stan dard heparin in proximal deep-vein thrombosis". Lancei 1992; 339: 441-445.
Hull R, Raskob G, Pineo G et al. "A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for pro phylaxis against deep-vein thrombosis after hip or Knee im plantation". N Engl J Med 1993; 329: 1370-1376
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 1994 Internal Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
